Pfizer gets ASA rap
This article was originally published in OTC Bulletin & The Rose Sheet
The UK Advertising Standards Authority (ASA) has rapped Pfizer Consumer Healthcare for making an unauthorised health claim in a press advertisement for its Imedeen Advanced Beauty Shot.
You may also be interested in...
Pfizer’s TV ad for Nexium Control short-term heartburn treatment implied consumers with persistent heartburn need not seek professional medical advice, UK Advertising Standards Authority says. Pfizer argued that information in the ad was in line with MHRA's approval for the drug’s indications and packaging warned consumers not to use more than 14 days.
The US FDA released five device-related close-out letters in March.
Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.